Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Crispr Therapeutics Ag (CRSP)  
$55.12 1.49 (2.63%) as of 4:30 Fri 11/7


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 90,950,000
Market Cap: 5.01(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $31.27 - $76.78
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 24.2
Insider 3/6 Months : 24.8
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CRISPR Therapeutics is a gene editing company focused on the development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) based therapeutics. CRISPR/Cas9 is a technology for gene editing, the process of altering specific sequences of genomic DNA. Co. is developing several gene-edited allogeneic cell therapy programs. Co.'s main product candidate, CTX001, is an investigational ex vivo CRISPR gene-edited therapy that is being evaluated for patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce fetal hemoglobin in red blood cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 1,009,812 1,016,812 1,016,812
Total Buy Value $0 $52,640,518 $52,954,466 $52,954,466
Total People Bought 0 2 3 3
Total Buy Transactions 0 2 3 3
Total Shares Sold 69,294 73,226 207,707 376,176
Total Sell Value $4,571,118 $4,712,434 $11,572,935 $22,845,326
Total People Sold 2 3 5 5
Total Sell Transactions 4 5 24 39
End Date 2025-08-10 2025-05-09 2024-11-08 2023-11-09

   
Records found: 542
  Page 1 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kulkarni Samarth Chief Executive Officer   •       •      –    2025-10-17 4 S $67.91 $3,456,279 D/D (50,895) 254,201 18%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2025-10-16 4 OE $0.00 $0 D/D 100,000 305,096     -
   Kasinger James R. General Counsel and Secretary   •       –      –    2025-10-14 4 S $66.60 $71,662 D/D (1,076) 83,402 18%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2025-10-14 4 S $66.60 $282,517 D/D (4,242) 205,096 18%     
   Kasinger James R. General Counsel and Secretary   •       –      –    2025-10-13 4 OE $0.00 $0 D/D 2,114 84,478     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2025-10-13 4 OE $0.00 $0 D/D 8,334 209,338     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2025-09-17 4 GD $0.00 $0 D/D 6,000 201,004     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2025-08-18 4 S $58.15 $760,660 D/D (13,081) 207,004 2%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2025-08-16 4 OE $0.00 $0 D/D 25,000 220,085     -
   Treco Douglas A   –       •      –    2025-08-06 4 B $57.03 $1,140,600 D/D 20,000 22,000 0.01 0%     
   George Simeon   –       •      –    2025-07-16 4 B $52.03 $51,499,918 I/I 989,812 1,730,179 0.01 3%     
   Morrison Briggs   –       •      –    2025-06-05 3/A IO $0.00 $0 D/D 0 5,209     -
   Patel Naimish Chief Medical Officer   •       –      –    2025-05-29 4 S $35.94 $141,316 D/D (3,932) 6,068 -92%     
   Patel Naimish Chief Medical Officer   •       –      –    2025-05-28 4 OE $0.00 $0 D/D 10,000 10,000     -
   Kasinger James R. General Counsel and Secretary   •       –      –    2025-03-21 4 S $41.23 $131,318 D/D (3,185) 81,729 -36%     
   Bruno Julianne Chief Operating Officer   •       –      –    2025-03-21 4 S $41.23 $70,668 D/D (1,714) 10,544 -36%     
   Prasad Raju Chief Financial Officer   •       –      –    2025-03-21 4 S $41.23 $90,582 D/D (2,197) 16,767 -36%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2025-03-21 4 S $41.23 $413,578 D/D (10,031) 195,085 -36%     
   Kasinger James R. General Counsel and Secretary   •       –      –    2025-03-20 4 OE $0.00 $0 D/D 6,250 84,914     -
   Bruno Julianne Chief Operating Officer   •       –      –    2025-03-20 4 OE $0.00 $0 D/D 3,750 12,258     -
   Prasad Raju Chief Financial Officer   •       –      –    2025-03-20 4 OE $0.00 $0 D/D 6,250 18,964     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2025-03-20 4 OE $0.00 $0 D/D 19,688 205,116     -
   Prasad Raju Chief Financial Officer   •       –      –    2025-03-17 4 S $41.80 $157,252 D/D (3,762) 12,714 -51%     
   Prasad Raju Chief Financial Officer   •       –      –    2025-03-14 4 OE $0.00 $0 D/D 10,000 16,476     -
   Kasinger James R. General Counsel and Secretary   •       –      –    2025-03-12 4 S $43.32 $48,345 D/D (1,116) 78,664 -52%     
  542 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us